Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report

Clin Lung Cancer. 2024 Mar;25(2):180-185.e1. doi: 10.1016/j.cllc.2024.01.001. Epub 2024 Jan 2.

Authors

Fatemeh Ardeshir-Larijani¹, Rohan Maniar², Subir Goyal¹, Patrick J Loehrer², Tieying Hou³, Victoria DeBrock², Hector Mesa⁴

Affiliations

¹ Winship Cancer Institute, Emory University, Atlanta, GA.
² Indiana University, Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN.
³ Department of Pathology and Laboratory Medicine, Indiana School of Medicine, Indianapolis, IN.
⁴ Department of Pathology and Laboratory Medicine, Indiana School of Medicine, Indianapolis, IN. Electronic address: hmesa@iu.edu.

PMID: 38242729
DOI: 10.1016/j.cllc.2024.01.001

No abstract available

Keywords: Molecular targeted therapy; Survival; Thymic carcinoma; Thymoma; Trop-2.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Lung Neoplasms*
Neoplasms, Glandular and Epithelial*
Thymus Neoplasms* / genetics
Thymus Neoplasms* / therapy

Supplementary concepts

Thymic epithelial tumor